BCHE and Alzheimer disease: Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine (Fig. 1), enhance cholinergic transmission by inhibiting cholinesterase at the synaptic cleft.6,7 To date, there are no viable treatments for Alzheimer's disease.8